FPS:NYSEForgent Power Solutions, Inc. Analysis
Data as of 2026-06-19 - not real-time
$63.41
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Forgent Power Solutions (FPS) is trading near its 52‑week high of $65.56 with the 20‑day SMA ($56.23) comfortably above the 50‑day ($45.49) and 200‑day ($39.66) averages, signaling a bullish price trend. The RSI of 66.3 suggests the stock is still in an upward momentum zone but approaching overbought territory, while the MACD histogram has turned slightly negative, hinting at a potential short‑term pullback. Technical indicators are mixed, yet the overall trend remains bullish, supported by strong analyst sentiment ("strong_buy") and recent hype from media personalities and hedge funds.
However, the fundamental picture is starkly at odds with the price action: a trailing P/E of 3,170.5 versus an industry average of 31.4, a DCF fair value of $0.30, and a debt‑to‑equity ratio exceeding 120% highlight severe overvaluation and financial strain. High beta (3.11) and 30‑day volatility near 93% amplify risk, while decreasing volume and a lack of free cash flow underscore liquidity concerns.
However, the fundamental picture is starkly at odds with the price action: a trailing P/E of 3,170.5 versus an industry average of 31.4, a DCF fair value of $0.30, and a debt‑to‑equity ratio exceeding 120% highlight severe overvaluation and financial strain. High beta (3.11) and 30‑day volatility near 93% amplify risk, while decreasing volume and a lack of free cash flow underscore liquidity concerns.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 8/10
Key Factors
- Bullish SMA crossover and price near resistance
- RSI still below 70 indicating momentum
- Strong analyst "strong_buy" rating and recent media endorsements
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Extreme overvaluation relative to DCF and industry peers
- High beta and volatility increasing price swings
- Decreasing volume trend and heavy debt load
Long Term
> 3 yearsCautious
Model confidence: 6/10
Key Factors
- Unsustainable valuation with P/E > 3,000
- Zero free cash flow and ROE/ROA of 0
- Elevated debt‑to‑equity ratio and potential regulatory headwinds
Key Metrics & Analysis
Financial Health
Revenue Growth103.40%
Profit Margin2.17%
P/E Ratio3170.5
Debt/Equity121.45
P/B Ratio34.7
Op. Cash Flow$28.0M
Industry P/E31.4
Technical Analysis
TrendBullish
RSI66.3
Support$44.14
Resistance$65.56
MA 20$56.23
MA 50$45.49
MA 200$39.66
MACDBearish
VolumeDecreasing
Fear & Greed Index91.46
Valuation
Fair Value$0.30
Target Price$58.30
Upside/Downside-8.06%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta3.11
Volatility92.80%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.